Cargando…

Personalized Immunotherapies for Type 1 Diabetes: Who, What, When, and How?

Our understanding of the immunopathological features of type 1 diabetes (T1D) has greatly improved over the past two decades and has shed light on disease heterogeneity dictated by multiple immune, metabolic, and clinical parameters. This may explain the limited effects of immunotherapies tested so...

Descripción completa

Detalles Bibliográficos
Autores principales:	Deligne, Claire, You, Sylvaine, Mallone, Roberto
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9031881/ https://www.ncbi.nlm.nih.gov/pubmed/35455658 http://dx.doi.org/10.3390/jpm12040542

Ejemplares similares

Oral Fc-Coupled Preproinsulin Achieves Systemic and Thymic Delivery Through the Neonatal Fc Receptor and Partially Delays Autoimmune Diabetes
por: Corcos, Noémie, et al.
Publicado: (2021)

Immunotherapy in Breast Cancer: When, How, and What Challenges?
por: Henriques, Beatriz, et al.
Publicado: (2021)

Epitope-based precision immunotherapy of Type 1 diabetes
por: Firdessa Fite, Rebuma, et al.
Publicado: (2023)

Driving personalized medicine forward: the who, what, when, and how of educating the health-care workforce
por: McCarthy, Jeanette J
Publicado: (2014)

Surveillance in testicular cancer: who, when, what and how?
por: Sohaib, S.A., et al.
Publicado: (2007)

T Cell Recognition of Autoantigens in Human Type 1 Diabetes: Clinical Perspectives
por: Mallone, Roberto, et al.
Publicado: (2011)

Rib fixation: Who, What, When?
por: de Moya, Marc, et al.
Publicado: (2017)

Palliative care in intensive care units: why, where, what, who, when, how
por: Mercadante, Sebastiano, et al.
Publicado: (2018)

Antigen-Based Immune Therapeutics for Type 1 Diabetes: Magic Bullets or Ordinary Blanks?
por: Culina, Slobodan, et al.
Publicado: (2011)

In Vitro Expansion of Anti-viral T Cells from Cord Blood by Accelerated Co-cultured Dendritic Cells
por: Kuranda, Klaudia, et al.
Publicado: (2018)

The Crucial Questions on Synovial Biopsy: When, Why, Who, What, Where, and How?
por: Ingegnoli, Francesca, et al.
Publicado: (2021)

Mechanical CPR: Who? When? How?
por: Poole, Kurtis, et al.
Publicado: (2018)

Presumption of guilt for T cells in type 1 diabetes: lead culprits or partners in crime depending on age of onset?
por: Carré, Alexia, et al.
Publicado: (2020)

To B or Not to B: (Anti)bodies of Evidence on the Crime Scene of Type 1 Diabetes?
por: Mallone, Roberto, et al.
Publicado: (2011)

Why, what, who, when and how? Hand hygiene measured in India?
por: Hemalatha, J, et al.
Publicado: (2015)

Colorectal Cancer Screening—Who, How, and When?
por: Bevan, Roisin, et al.
Publicado: (2018)

What? When? And How?
por: Hutchinson, Jonathan
Publicado: (1890)

Immunotherapy in Head and Neck Cancer When, How, and Why?
por: Pereira, Daniela, et al.
Publicado: (2022)

The countdown to type 1 diabetes: when, how and why does the clock start?
por: Ziegler, Anette-Gabriele
Publicado: (2023)

How to Find an Academic Position After Residency: Who, What, When, Where, Why, and How
por: Mason, Bonnie Simpson, et al.
Publicado: (2018)

Driving Assessment for Persons with Dementia: How and when?
por: Camilleri, Lara, et al.
Publicado: (2023)

Navigating the who, where, what, when, how and why of trauma exposure and response
por: Vallières, Frédérique, et al.
Publicado: (2021)

Aiming for the end of the COVID-19 pandemic: the what, how, who, where, and when
por: Soriano, Joan B., et al.
Publicado: (2023)

Editorial: Footprints of Immune Cells in the Type 1 Diabetic Pancreas
por: Brusko, Todd M., et al.
Publicado: (2021)

Immunotherapy in COVID-19: why, who, and when?
por: Sinha, Pratik, et al.
Publicado: (2021)

Nanotherapeutics Plus Immunotherapy in Oncology: Who Brings What to the Table?
por: Timon-David, Elise, et al.
Publicado: (2022)

Who, when, where, how!
Publicado: (1960)

Typography, when, who, how /
Publicado: (1998)

Citrate: How to Get Started and What, When, and How to Monitor?
por: Honore, Patrick M., et al.
Publicado: (2018)

Immunotherapy in myeloma: Why, when and how?
por: van de Donk, Niels W.C.J.
Publicado: (2018)

Treatment in advanced colorectal cancer: what, when and how?
por: Chau, I, et al.
Publicado: (2009)

Fungal Genomics in Respiratory Medicine: What, How and When?
por: Brackin, Amelie P., et al.
Publicado: (2021)

Hepatitis C Therapy in Renal Patients: Who, How, When?
por: Isnard Bagnis, Corinne, et al.
Publicado: (2016)

Follow-Up of Celiac Disease in Adults: “When, What, Who, and Where”
por: Mulder, Chris J. J., et al.
Publicado: (2023)

Screening for MAFLD: who, when and how?
por: Pal, Shreya C., et al.
Publicado: (2023)

Mild Hypothyroidism in Childhood: Who, When, and How Should Be Treated?
por: Vigone, Maria Cristina, et al.
Publicado: (2018)

Screening for nonalcoholic fatty liver disease-when, who and how?
por: Dietrich, Christoph G, et al.
Publicado: (2021)

Treating early psychosis: who, what, and when?
por: Cornblatt, Barbara A., et al.
Publicado: (2005)

Evolutionary Psychology Lecture 2: Thinking about the Future: Whether, When, Why, How, Who, What ... and So What?
por: Baumeister, Roy
Publicado: (2019)

Transplanting Cells for Spinal Cord Repair: Who, What, When, Where and Why?
por: Zholudeva, Lyandysha V., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_bhtdensthnlkkb7ijmogqp6bfr